Products for Research Use Only
RegisterLogin

SSGJ-707

CAT: 0931-T9901A-1886-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0931-T9901A-1886-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Target
PD-1/PD-L1, VEGFR
Related Pathways
Apoptosis, Tyrosine Kinase/Adaptors, Angiogenesis, Immunology/Inflammation, Cell Cycle/Checkpoint
Bioactivity
SSGJ-707 is a bispecific recombinant humanized IgG4 monoclonal antibody inhibitor that targets PD-1 and VEGF. It is applicable in cancer research, particularly for advanced non-small cell lung cancer (NSCLC) and recurrent endometrial cancer.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C

Related Products

CatalogName
T9901A-1804-01SSGJ-608
T9901A-1702-01SSGJ-613
T14509-01BAY-707
T25228-01CG-707
T9901A-811-01NGM-707
T23494-01UCM 707
T16921-01SPL-707
T33855-01P-707
T69776-01BAY-707 acetate
TMAC-04128-01Anti-Phospho-NTRK2 (Tyr706, 707) Polyclonal Antibody

Alternative Products

CatalogName
HY-P991628-01SSGJ-707
HY-P991597SSGJ-608
HS870023-01Anti-Human CD279/PDCD1/PD1 & VEGF Bispecific Recombinant Antibody (SSGJ-707)
WA5109-01U-Blot® Human CD279/PDCD1/PD1 & VEGF Bispecific Antibody (SSGJ-707)
HY-P991522SSGJ-613
BA8593-1SPL-707
BA4013-5.1BAY-707
B6901-25UCM 707
463113NSC 707
MBS131323SGC-707

Popular Products